10:47 AM EST - Medicenna Therapeutics Corp : Today announced a grant of five patents covering the Company’s IL-2 and IL-4 Superkine platforms. These patents strengthen Medicenna’s intellectual property (IP) position across key markets and further support the Company’s lead clinical and preclinical programs. Medicenna Therapeutics Corp
shares T.MDNA are trading up $0.02 at $0.88.
